CYTOSORBENTS CORP (CTSO)

US23283X2062 - Common Stock

0.9366  +0.02 (+1.8%)

After market: 0.944 +0.01 (+0.79%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
37.74M36.35M34.69M43.17M41.00M
Cost Of Goods
14.07M13.96M13.96M11.05M11.05M
Gross Profit
23.67M22.39M20.73M32.12M29.95M
Operating Expenses
44.98M52.67M52.25M54.86M40.32M
Research and Development
9.72M15.73M15.12M16.38M8.81M
Selling, General, and Administrative Expenses
35.26M36.94M37.14M38.48M31.51M
Operating Income
-21.31M-30.27M-31.52M-22.74M-10.37M
Interest Income/Expense
2.54M1.79M-2.32M-2.55M1.41M
Other Income/Expense
N/A96.75K-70.00KN/AN/A
Non Recurring Items
-773.00K-936.00KN/AN/AN/A
Income Before Taxes
-19.48M-29.32M-33.91M-25.29M-8.96M
Income Tax
N/A-813.74K-1.09M-740.00K-1.13M
Net Income
-18.67M-28.51M-32.81M-24.56M-7.84M
EBITDA
-19.60M-28.81M-30.64M-22.01M-9.71M
 
Per Share Data
EPS Diluted Total Ops
-0.36-0.64-0.75-0.57-0.20
Non GAAP EPS
-0.37-0.65-0.76-0.57-0.20
 
Statistics
Gross Profit Margin
62.71%61.60%59.76%74.40%73.05%
Profit Margin
-49.47%-78.43%-94.58%-56.89%-19.12%
Operating Profit Margin
-56.46%-83.28%-90.86%-52.68%-25.29%

All data in USD

Charts